share_log

翰森製藥：截至二零二三年十二月三十一日止月份之股份發行人的證券變動月報表

HANSOH PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Jan 2 04:09
Summary by Moomoo AI
翰森製藥於2024年1月2日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份在該月份均無變動，維持在20,000,000,000股，每股面值0.00001港元，總額200,000港元。此外，公司的普通股結存數量為5,933,350,070股，本月內亦無增減。報告中提及的零息可換股債券（證券代號40546），於2021年1月22日發行，將於2026年到期，發行總額為596,000,000美元，本月內無變動，相關的新股份數目為77,881,820股。報告最後確認，本月內沒有發行新證券，並由聯席公司秘書鍾勝利女士呈交。
翰森製藥於2024年1月2日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份在該月份均無變動，維持在20,000,000,000股，每股面值0.00001港元，總額200,000港元。此外，公司的普通股結存數量為5,933,350,070股，本月內亦無增減。報告中提及的零息可換股債券（證券代號40546），於2021年1月22日發行，將於2026年到期，發行總額為596,000,000美元，本月內無變動，相關的新股份數目為77,881,820股。報告最後確認，本月內沒有發行新證券，並由聯席公司秘書鍾勝利女士呈交。
Hansen Pharmaceuticals filed with Hong Kong Trading and Clearing Limited on January 2, 2024 the Monthly Securities Change Report for the year ended December 31, 2023. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 20,000,000,000 shares with a face value of HK$0.00001 per share for a total of HK$200,000. In addition, the number of ordinary shares outstanding of the company was 5,933,350,070 shares, which did not increase during the month. The Zero-Dividend Convertible Bond (Securities Code 40546) referred to in the report, issued on January 22, 2021, will mature in 2026 with a total issuance of $596 million, unchanged during the month, and the corresponding number of new shares is 77,881,820 shares. The report finally confirms that no new securities have been issued this month and was presented by Ms Chung Shengli, Joint Corporate Secretary.
Hansen Pharmaceuticals filed with Hong Kong Trading and Clearing Limited on January 2, 2024 the Monthly Securities Change Report for the year ended December 31, 2023. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 20,000,000,000 shares with a face value of HK$0.00001 per share for a total of HK$200,000. In addition, the number of ordinary shares outstanding of the company was 5,933,350,070 shares, which did not increase during the month. The Zero-Dividend Convertible Bond (Securities Code 40546) referred to in the report, issued on January 22, 2021, will mature in 2026 with a total issuance of $596 million, unchanged during the month, and the corresponding number of new shares is 77,881,820 shares. The report finally confirms that no new securities have been issued this month and was presented by Ms Chung Shengli, Joint Corporate Secretary.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more